# DoD Prostate Cancer, Translational Science Award

Source: https://welltoldgrants.com/grants/ht9425-23-pcrp-tsa-dod-prostate-cancer-translational-science-award/  
Official notice: https://www.grants.gov/search-results-detail/347773

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 5 awards worth $7.2 million in total. Applications closed on August 24, 2023.

| Field | Value |
|---|---|
| Opportunity number | HT9425-23-PCRP-TSA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | August 24, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 5 |
| Total funding | $7.2 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY23 PCRP Translational Science Award mechanism supports advanced translational research that will foster transformation of promising ideas in prostate cancer into clinical applications, ultimately providing a solution to one or more of the FY23 PCRP Overarching Challenges. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may originate from a laboratory discovery, population-based studies, or a clinician’s firsthand knowledge of patient care. Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside but can include a reciprocal flow of ideas and information between basic science and clinical science (bench to bedside and/or bedside to bench). New for FY23! The intent of the Translational Science Award is expanded for FY23 to include support for implementation science studies that will bridge the gap between clinical research and real-world implementation. Even after information, tools, and interventions have been successfully evaluated in their intended populations, the development of knowledge to support their broader dissemination and implementation has often remained outside the scope, limiting the impact on the intended patient population(s). As part of the TSA, implementation science studies are expected to bridge the gap between research, practice, and policy by building a knowledge base on how interventions, clinical practices/guidelines, tools, and policies can be deployed to targeted populations at the appropriate time and point of need. An implementation science study is defined as the scientific study of the use of strategies to adopt and integrate evidence-based health interventions into clinical and community settings in order to improve patient outcomes and benefit population health.

## Questions people ask

### Is HT9425-23-PCRP-TSA still open?

No. It closed on August 24, 2023. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Prostate Cancer, Translational Science Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Prostate Cancer, Translational Science Award?

Closed August 24, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $7.2 million in total across about 5 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.